Braze (BRZE) vs Cellebrite DI (CLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Braze (BRZE) has outperformed Cellebrite DI (CLBT) over the past year, gaining 3.1% versus a loss of 39.3%. Braze is the larger company by market cap ($3.22 billion vs $2.82 billion), about 1.1 times the size. On valuation, Cellebrite DI trades at a lower forward P/E (17.2x vs 28.8x for Braze).
Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus -17.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRZE | CLBT |
|---|---|---|
| Share price | $28.31 | $11.24 |
| Market cap | $3.22B | $2.82B |
| 1-day change | -0.53% | +0.09% |
| YTD return | -17.00% | -37.74% |
| 1-year return | +3.08% | -39.29% |
| 5-year return | — | +8.24% |
| P/E ratio (TTM) | — | 48.85 |
| Forward P/E | 28.83 | 17.20 |
| EPS (TTM) | $-1.03 | $0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $738.18M | $475.68M |
| Revenue growth (YoY) | +24.40% | +18.56% |
| Net income (latest FY) | $-131.29M | $78.33M |
| Gross margin | 67.15% | 84.20% |
| Operating margin | -19.61% | 13.98% |
| Net margin | -17.79% | 16.47% |
| 52-week high | $37.33 | $19.98 |
| 52-week low | $15.26 | $9.58 |
| Distance from 52-week high | -24.16% | -43.77% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +31.76% | +36.72% |
| Average volume | 2.52M | 2.96M |
| Shares outstanding | 113.58M | 251.34M |
| Employees | 1,988 | 1,285 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BRZE has outperformed CLBT by 42.4 percentage points over the past year.
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus -17.8 cents for Braze.
- Braze grew revenue faster in its latest fiscal year (+24.40% vs +18.56%).
About Braze
BRZE stock →Braze, Inc. operates a customer engagement platform that provides interactions between consumers and brands worldwide.
Technology · Computer Software: Prepackaged Software · 1,988 employees
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
BRZE vs CLBT FAQ
Which is bigger, Braze or Cellebrite DI?
Braze (BRZE) is larger, with a market capitalization of $3.22B compared with $2.82B for Cellebrite DI (CLBT).
Which stock has performed better over the past year, BRZE or CLBT?
BRZE returned +3.08% over the past 12 months, compared with -39.29% for CLBT (price return, excluding dividends). Past performance does not predict future results.
Are Braze and Cellebrite DI in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.